PER 0.00% 10.0¢ percheron therapeutics limited

Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-43

  1. 373 Posts.
    lightbulb Created with Sketch. 20
    To all our long suffering holders congrats
    its been frustrating and bumpy ride
    but our patience and belief has prevailed
    hopefully we can finally move forward
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.